Yibin Kang

인용

	전체	2020년 이후
서지정보	50607	23099
h-index	94	64
i10-index	183	156

6000

3000

1500

4500

200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025176 217 264 428 512 559 680 747 883 1363 1508 1902 2304 2606 3047 3052 3270 3540 4179 5164 4744 4221 4077 701

공개 액세스

모두 보기

자료 129개

자료 4개

공개

비공개

재정 지원 요구사항 기준

공동 저자

Joan MassagueMemorial Sloan Kettering Cancer Cencermskcc.org의 이메일 확인됨
Guohong HuInstitute of Nutrition and Health, Chinese Academy of Sciencessibs.ac.cn의 이메일 확인됨
Minhong ShenWayne State Universitywayne.edu의 이메일 확인됨
Toni Celià-TerrassaGroup leader at Hospital del Mar Research Institute of Barcelona (HMRI))imim.es의 이메일 확인됨
Masa AleckovicPostdoctoral Fellow, Dana-Farber Cancer Institute/Harvard Medical Schooldfci.harvard.edu의 이메일 확인됨
Hanqiu Zheng, Ph.D.School of Medicine, Tsinghua Universitytsinghua.edu.cn의 이메일 확인됨
Hector PeinadoSpanish National Cancer Research Center (CNIO)cnio.es의 이메일 확인됨
Nilay Sethi, MD, PhDDana Farber Cancer Institutedfci.harvard.edu의 이메일 확인됨
Bruce G HafftyRutgers Robert Wood Johnson Medical School and Cancer Institute of New Jerseycinj.rutgers.edu의 이메일 확인됨
Liling WanUniversity of PennsylvaniaPennmedicine.upenn.edu의 이메일 확인됨
Bryan R. CullenProfessor of Molecular Genetics and Microbiology, Duke Universityduke.edu의 이메일 확인됨
Jacqueline BrombergMemorial Sloan Ketteringmskcc.org의 이메일 확인됨
Rosandra KaplanNational Institutes of Health/ National Cancer Institutemail.nih.gov의 이메일 확인됨
Irina MateiWeill Cornell Medicinemed.cornell.edu의 이메일 확인됨
Gaorav P. GuptaUniversity of North Carolina at Chapel Hillmed.unc.edu의 이메일 확인됨
Wenyang LiPostdoctoral Fellow, Massachusetts General Hospital - Harvard Medical Schoolmgh.harvard.edu의 이메일 확인됨
Theresa GuiseProfessor, MD Anderson Cancer Center, University of Texasmdanderson.org의 이메일 확인됨
Heath SmithPostdoctoral Fellow, Princeton Universityprinceton.edu의 이메일 확인됨
Tianhua zhouZhejiang universityzju.edu.cn의 이메일 확인됨
Nicole M. Aiello-CouzoPrinceton Universityprinceton.edu의 이메일 확인됨

팔로우

Yibin Kang

Warner-Lambert/Parke-Davis Professor of Molecular Biology, Princeton University

princeton.edu의 이메일 확인됨

metastasis breast cancer bone tumor-stromal interaction mammary stem cell


제목 서지정보순 정렬 연도순 정렬 제목순 정렬	인용 인용	연도
Tumour exosome integrins determine organotropic metastasis A Hoshino, B Costa-Silva, TL Shen, G Rodrigues, A Hashimoto, ... Nature 527 (7578), 329-335, 2015	4984	2015
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET H Peinado, M Alečković, S Lavotshkin, I Matei, B Costa-Silva, ... Nature medicine 18 (6), 883-891, 2012	4081	2012
A multigenic program mediating breast cancer metastasis to bone Y Kang, PM Siegel, W Shu, M Drobnjak, SM Kakonen, C Cordón-Cardo, ... Cancer cell 3 (6), 537-549, 2003	3207	2003
The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2 M Korpal, ES Lee, G Hu, Y Kang Journal of Biological Chemistry 283 (22), 14910-14914, 2008	2018	2008
Epithelial-mesenchymal transitions: twist in development and metastasis Y Kang, J Massagué Cell 118 (3), 277-279, 2004	1949	2004
Pre-metastatic niches: organ-specific homes for metastases H Peinado, H Zhang, IR Matei, B Costa-Silva, A Hoshino, G Rodrigues, ... Nature Reviews Cancer 17 (5), 302-317, 2017	1823	2017
Guidelines and definitions for research on epithelial–mesenchymal transition J Yang, P Antin, G Berx, C Blanpain, T Brabletz, M Bronner, K Campbell, ... Nature reviews Molecular cell biology 21 (6), 341-352, 2020	1770	2020
Extracellular vesicle and particle biomarkers define multiple human cancers A Hoshino, HS Kim, L Bojmar, KE Gyan, M Cioffi, J Hernandez, ... Cell 182 (4), 1044-1061. e18, 2020	989	2020
Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors AJ Minn, Y Kang, I Serganova, GP Gupta, DD Giri, M Doubrovin, ... The Journal of clinical investigation 115 (1), 44-55, 2005	954	2005
Epithelial-mesenchymal plasticity in cancer progression and metastasis W Lu, Y Kang Developmental cell 49 (3), 361-374, 2019	896	2019
Beyond tumorigenesis: cancer stem cells in metastasis F Li, B Tiede, J Massagué, Y Kang Cell research 17 (1), 3-14, 2007	879	2007
Tumor metastasis: moving new biological insights into the clinic L Wan, K Pantel, Y Kang Nature medicine 19 (11), 1450-1464, 2013	844	2013
Hypoxia and hypoxia-inducible factors: master regulators of metastasis X Lu, Y Kang Clinical cancer research 16 (24), 5928-5935, 2010	828	2010
A self-enabling TGFβ response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells Y Kang, CR Chen, J Massagué Molecular cell 11 (4), 915-926, 2003	773	2003
Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization M Korpal, BJ Ell, FM Buffa, T Ibrahim, MA Blanco, T Celià-Terrassa, ... Nature medicine 17 (9), 1101-1108, 2011	739	2011
Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells N Sethi, X Dai, CG Winter, Y Kang Cancer cell 19 (2), 192-205, 2011	691	2011
E2F4/5 and p107 as Smad cofactors linking the TGFβ receptor to c-myc repression CR Chen, Y Kang, PM Siegel, J Massagué Cell 110 (1), 19-32, 2002	690	2002
Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway Y Kang, W He, S Tulley, GP Gupta, I Serganova, CR Chen, ... Proceedings of the National Academy of Sciences 102 (39), 13909-13914, 2005	642	2005
VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors X Lu, E Mu, Y Wei, S Riethdorf, Q Yang, M Yuan, J Yan, Y Hua, BJ Tiede, ... Cancer cell 20 (6), 701-714, 2011	587	2011
Context-dependent EMT programs in cancer metastasis NM Aiello, Y Kang Journal of Experimental Medicine 216 (5), 1016-1026, 2019	534	2019

현재 시스템이 작동되지 않습니다. 나중에 다시 시도해 주세요.

학술자료 1–20

연간 인용횟수

중복된 서지정보

병합된 서지정보

공동 저자 추가공동 저자

팔로우

인용

공동 저자